SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SHANGHAI, Sept. 12, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized leader in medical devices for pulmonary hypertension (PH) and heart failure (HF), is...
East-West Marketing Leaders Unite as AI Revolution Transforms Hong Kong HONG KONG, Sept. 12, 2025 /PRNewswire/ -- Artificial Intelligence (AI) is transforming our...
BEIJING, Sept. 12, 2025 /PRNewswire/ -- A news report from en.qstheory.cn: Sci-tech innovation is the core element for developing new quality productive forces. In...
SHANGRAO, China, Sept. 12, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative...
Singapore Finternet pioneer backs global cycling showcase, spotlighting trust, financial literacy, and inclusive growth across Asia and Africa SINGAPORE, Sept. 12, 2025 /PRNewswire/...